Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryosuke Nakano

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
Biochemical Pharmacology|May 13, 2008
ASP8497 is a novel selective and competitive dipeptidyl peptidase-IV inhibitor with antihyperglycemic activityAkiko Matsuyama-Yokono, Atsuo Tahara, Ryosuke Nakano, et al.
Metabolism: Clinical and Experimental|February 17, 2009
Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic miceAkiko Matsuyama-Yokono, Atsuo Tahara, Ryosuke Nakano, et al.
Biopharmaceutics & Drug Disposition|August 12, 2018
Metabolism of steroids by cytochrome P450 2C9 variantsTomohide Uno, Ryosuke Nakano, Risa Kitagawa, et al.
Hepatology Communications|June 21, 2022
Acute portal hypertension using portal vein ligation abrogates TRAIL expression of liver-resident NK cellsYuki Imaoka, Koki Sato, Masahiro Ohira, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|March 11, 2024
[Well Differentiated Liposarcoma of a Lung:Report of a Case]Jun Yamamoto, Yoshikane Yamauchi, Ryosuke Nakano, et al.
Frontiers in Immunology|July 15, 2021
Dendritic Cell-Mediated Regulation of Liver Ischemia-Reperfusion Injury and Liver Transplant RejectionRyosuke Nakano, Lillian M Tran, David A Geller, et al.
Kidney International Reports|January 16, 2026
Time-unrestricted, Immune Surveillance-Guided Desensitization Enables Kidney Transplantation in Highly Sensitized PatientsKentaro Ide, Hiroyuki Tahara, Ryosuke Nakano, et al.
Biochemical Pharmacology|March 12, 2003
Differential effects of YM440 a hypoglycemic agent on binding to a peroxisome proliferator-activated receptor gamma and its transactivationEiji Kurosaki, Ryosuke Nakano, Akiyoshi Shimaya, et al.
Transplantation Proceedings|April 8, 2023
Genetic Polymorphisms in Follicular Helper T Cell-Related Molecules Predispose Patients to De Novo Donor-Specific Antibody Formation After Kidney TransplantationKosuke Ono, Kentaro Ide, Ryosuke Nakano, et al.
Human Immunology|September 10, 2024
Polymorphisms in genes involved in regulating follicular helper T cell differentiation predict de novo donor-specific antibody formation after liver transplantationKosuke Ono, Kentaro Ide, Ryosuke Nakano, et al.
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Biochemical Pharmacology|May 13, 2008
ASP8497 is a novel selective and competitive dipeptidyl peptidase-IV inhibitor with antihyperglycemic activityAkiko Matsuyama-Yokono, Atsuo Tahara, Ryosuke Nakano, et al.
Metabolism: Clinical and Experimental|February 17, 2009
Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic miceAkiko Matsuyama-Yokono, Atsuo Tahara, Ryosuke Nakano, et al.
Biopharmaceutics & Drug Disposition|August 12, 2018
Metabolism of steroids by cytochrome P450 2C9 variantsTomohide Uno, Ryosuke Nakano, Risa Kitagawa, et al.
Hepatology Communications|June 21, 2022
Acute portal hypertension using portal vein ligation abrogates TRAIL expression of liver-resident NK cellsYuki Imaoka, Koki Sato, Masahiro Ohira, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|March 11, 2024
[Well Differentiated Liposarcoma of a Lung:Report of a Case]Jun Yamamoto, Yoshikane Yamauchi, Ryosuke Nakano, et al.
Frontiers in Immunology|July 15, 2021
Dendritic Cell-Mediated Regulation of Liver Ischemia-Reperfusion Injury and Liver Transplant RejectionRyosuke Nakano, Lillian M Tran, David A Geller, et al.
Kidney International Reports|January 16, 2026
Time-unrestricted, Immune Surveillance-Guided Desensitization Enables Kidney Transplantation in Highly Sensitized PatientsKentaro Ide, Hiroyuki Tahara, Ryosuke Nakano, et al.
Biochemical Pharmacology|March 12, 2003
Differential effects of YM440 a hypoglycemic agent on binding to a peroxisome proliferator-activated receptor gamma and its transactivationEiji Kurosaki, Ryosuke Nakano, Akiyoshi Shimaya, et al.
Transplantation Proceedings|April 8, 2023
Genetic Polymorphisms in Follicular Helper T Cell-Related Molecules Predispose Patients to De Novo Donor-Specific Antibody Formation After Kidney TransplantationKosuke Ono, Kentaro Ide, Ryosuke Nakano, et al.
Human Immunology|September 10, 2024
Polymorphisms in genes involved in regulating follicular helper T cell differentiation predict de novo donor-specific antibody formation after liver transplantationKosuke Ono, Kentaro Ide, Ryosuke Nakano, et al.
Pageof 10